Atlas Trials

Serum Alpha-fetoprotein Levels and Response to Direct Antiviral Therapy in Patients With Chronic Hepatitis C

Clinical trial NCT03402165 · UNKNOWN

Trial details

NCT number
NCT03402165
Sponsor
Sherief Abd-Elsalam
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Hepatitis C
Start date
2017-01-01
Primary completion
2022-12-01
Enrollment
1200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.